Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

In this page

Clinical Trial

NCT07303296 Recruiting, Active
REVISE

Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients (REVISE)

Phase 2
Interventional

Disease

Disease type

Leber Hereditary Optic Neuropathy (LHON)

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

22/01/2026

Closing date

30/06/2028

Inclusion criteria :

More

Exclusion criteria :

More

Funding

Industry

Members involved

Main investigators

Pr Isabelle Audo

Representative

France

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Dr Catherine Vignal-Clermont

France

Neuro-Ophthalmology Rare Diseases (WG2)
Working Group Leader
See more

ERN EYE member investigating site

HCP : Principal investigators